adamantane has been researched along with gv 150013x in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnaby, JR; Kajbaf, M; Pellegatti, M; Rossato, P | 1 |
| Barnaby, JR; Kajbaf, M; Marchioro, C; Pellegatti, M | 1 |
| Crespi, F | 1 |
| Beani, L; Bianchi, C; Ferraro, L; Reggiani, A; Trist, D | 1 |
| Dressman, JB; Efthymiopoulos, C; Galia, E; Nicolaides, E; Reppas, C | 1 |
| Dressman, JB; Nicolaides, E; Reppas, C; Symillides, M | 1 |
| Beani, L; Bianchi, C; Cavallini, S; Marino, S; Rodi, D; Siniscalchi, A | 1 |
| Beani, L; Bianchi, C; Cavallini, S; Ferraro, L; Marino, S; Rodi, D; Siniscalchi, A | 1 |
| Antonioli, L; Baschiera, F; Blandizzi, C; Colucci, R; Del Tacca, M; Fornai, M; Ghisu, N; Gori, G; Tuccori, M | 1 |
| Antonioli, L; Baschiera, F; Blandizzi, C; Buccianti, P; Chiarugi, M; Colucci, R; Crema, F; Del Tacca, M; Fornai, M; Ghisu, N; Tuccori, M | 1 |
| Azema, J; Baltas, M; Clerc, P; Cordomi, A; De, K; Escrieut, C; Fourmy, D; Gigoux, V; Magnan, R; Masri, B; Niu, F; Tikhonova, IG | 1 |
11 other study(ies) available for adamantane and gv 150013x
| Article | Year |
|---|---|
Metabolism of a novel CCK-B antagonist in rat, dog and human liver microsomes.
Topics: Adamantane; Adult; Animals; Chromatography, High Pressure Liquid; Dogs; Female; Humans; Hydroxylation; Male; Mass Spectrometry; Microsomes, Liver; Middle Aged; Molecular Structure; Phenylurea Compounds; Rats; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1998 |
In vivo metabolism of a novel cholecystokinin B (CCK-B) antagonist in rat and dog plasma and rat faeces.
Topics: Adamantane; Animals; Chromatography, High Pressure Liquid; Dogs; Feces; Female; Male; Nuclear Magnetic Resonance, Biomolecular; Phenylurea Compounds; Radiochemistry; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spectrophotometry, Ultraviolet | 1998 |
The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats.
Topics: Adamantane; Alcohol Drinking; Alcoholism; Animals; Benzodiazepinones; Cocaine; Cocaine-Related Disorders; Drinking; Male; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide | 1998 |
Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
Topics: Adamantane; Animals; Cerebral Cortex; Cholecystokinin; Culture Techniques; Electric Stimulation; gamma-Aminobutyric Acid; Male; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1999 |
Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data.
Topics: Adamantane; Anti-Bacterial Agents; Antimalarials; Atovaquone; Biopharmaceutics; Chemical Phenomena; Chemistry, Physical; Chromans; Chromatography, High Pressure Liquid; Food-Drug Interactions; Lactams; Naphthoquinones; Phenylurea Compounds; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prodrugs; Solubility; Solvents; Spectrophotometry, Ultraviolet; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration.
Topics: Adamantane; Administration, Oral; Algorithms; Anti-Bacterial Agents; Antifungal Agents; Atovaquone; Chemical Phenomena; Chemistry, Physical; Chromans; Humans; Hypoglycemic Agents; Lactams; Lipids; Models, Chemical; Naphthoquinones; Pharmaceutical Preparations; Pharmacokinetics; Phenylurea Compounds; Solubility; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Effects of cholecystokinin tetrapeptide (CCK(4)) and anxiolytic drugs on the electrically evoked [(3)H]5-hydroxytryptamine outflow from rat cortical slices.
Topics: Adamantane; Animals; Anti-Anxiety Agents; Buspirone; Cerebral Cortex; Diazepam; Electric Stimulation; Female; GABA Modulators; Glutamic Acid; In Vitro Techniques; Male; Phenylurea Compounds; Raphe Nuclei; Rats; Receptors, GABA-A; Serotonin; Serotonin Receptor Agonists; Tetragastrin | 2001 |
Effects of cholecystokinin tetrapeptide (CCK(4)) and of anxiolytic drugs on GABA outflow from the cerebral cortex of freely moving rats.
Topics: Adamantane; Animals; Anti-Anxiety Agents; Buspirone; Cerebral Cortex; Diazepam; Epidural Space; Female; Flumazenil; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Motor Activity; Muscle Relaxants, Central; Nerve Tissue Proteins; Phenylurea Compounds; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tetragastrin | 2003 |
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
Topics: Adamantane; Animals; Cholecystokinin; Colon; Devazepide; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Gastrins; Guinea Pigs; Hormone Antagonists; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Nootropic Agents; Perfusion; Phenylurea Compounds; Potassium Chloride; Receptor, Cholecystokinin B; Sincalide | 2007 |
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.
Topics: Adamantane; Arginine; Colon; Dose-Response Relationship, Drug; Electric Stimulation; Gastrointestinal Motility; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nootropic Agents; Phenylurea Compounds; Potassium Chloride; Receptor, Cholecystokinin B; Sincalide; Tetrodotoxin | 2007 |
Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
Topics: Adamantane; Arrestins; beta-Arrestin 2; beta-Arrestins; Binding Sites; Enzyme Activation; Humans; Microscopy, Confocal; Models, Molecular; Molecular Structure; Mutation; Phenylurea Compounds; Protein Conformation; Receptor, Cholecystokinin B; Signal Transduction; Type C Phospholipases; Up-Regulation | 2013 |